EA202090066A1 - THERAPEUTIC FOR THE TREATMENT OF ASPIRATED PNEUMONIA, PULMONARY FORCING OR LUNG ABCESS - Google Patents

THERAPEUTIC FOR THE TREATMENT OF ASPIRATED PNEUMONIA, PULMONARY FORCING OR LUNG ABCESS

Info

Publication number
EA202090066A1
EA202090066A1 EA202090066A EA202090066A EA202090066A1 EA 202090066 A1 EA202090066 A1 EA 202090066A1 EA 202090066 A EA202090066 A EA 202090066A EA 202090066 A EA202090066 A EA 202090066A EA 202090066 A1 EA202090066 A1 EA 202090066A1
Authority
EA
Eurasian Patent Office
Prior art keywords
treatment
pulmonary
pneumonia
aspirated
forcing
Prior art date
Application number
EA202090066A
Other languages
Russian (ru)
Inventor
Масааки Одадзима
Саёко Таниока
Такааки Суноути
Асако Табути
Original Assignee
Керин Фармасьютикал Ко., Лтд.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Керин Фармасьютикал Ко., Лтд. filed Critical Керин Фармасьютикал Ко., Лтд.
Publication of EA202090066A1 publication Critical patent/EA202090066A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4375—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring heteroatom, e.g. quinolizines, naphthyridines, berberine, vincamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Настоящее изобретение относится к безопасному и более эффективному терапевтическому средству для лечения инфекций дыхательных путей. Решение: терапевтическое средство для лечения аспирационной пневмонии, легочного нагноения или абсцесса легких, включающее в качестве активного ингредиента 7-[(3S,4S)-3-{(циклопропиламино)метил}-4-фторпирролидин-1-ил]-6-фтор-1-(2-фторэтил)-8-метокси-4-оксо-1,4-дигидрохинолин-3-карбоновую кислоту или ее фармацевтически приемлемую соль.The present invention relates to a safer and more effective therapeutic agent for the treatment of respiratory tract infections. Solution: A therapeutic agent for the treatment of aspiration pneumonia, pulmonary suppuration or lung abscess, containing as an active ingredient 7-[(3S,4S)-3-{(cyclopropylamino)methyl}-4-fluoropyrrolidin-1-yl]-6-fluoro -1-(2-fluoroethyl)-8-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic acid or a pharmaceutically acceptable salt thereof.

EA202090066A 2018-03-30 2018-06-15 THERAPEUTIC FOR THE TREATMENT OF ASPIRATED PNEUMONIA, PULMONARY FORCING OR LUNG ABCESS EA202090066A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2018068159 2018-03-30
PCT/JP2018/022846 WO2018230686A1 (en) 2017-06-16 2018-06-15 Therapeutic agent for aspiration pneumonia, lung suppuration, or lung abscess

Publications (1)

Publication Number Publication Date
EA202090066A1 true EA202090066A1 (en) 2020-04-15

Family

ID=64660738

Family Applications (1)

Application Number Title Priority Date Filing Date
EA202090066A EA202090066A1 (en) 2018-03-30 2018-06-15 THERAPEUTIC FOR THE TREATMENT OF ASPIRATED PNEUMONIA, PULMONARY FORCING OR LUNG ABCESS

Country Status (3)

Country Link
CN (1) CN116549446A (en)
EA (1) EA202090066A1 (en)
WO (1) WO2018230686A1 (en)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1666477E (en) 2003-09-10 2013-08-28 Kyorin Seiyaku Kk 7-(4-substituted 3- cyclopropylaminomethyl-1- pyrrolidinyl) q uinolonecarboxylic acid derivative
SA112330992B1 (en) 2011-11-10 2015-09-13 كيورين فارماسوتيكال كو.، ليمتد Crystalline form of the 7-{(3S,4S)-3 [(cyclopropylamino)methyl]-4- fluoropyrrolidine-1-YL}-6-fluoro-1-(2-fluoroethyl)-8-methoxy-4-OXO- 1,4-dihydroquinoline-3-carboxylic acid
US20180042918A1 (en) * 2015-03-13 2018-02-15 Kyorin Pharmaceutical Co., Ltd. Respiratory infection treating agent
CA2987879A1 (en) 2015-06-02 2016-12-08 Kyorin Pharmaceutical Co., Ltd. Aqueous drug

Also Published As

Publication number Publication date
CN116549446A (en) 2023-08-08
WO2018230686A1 (en) 2018-12-20

Similar Documents

Publication Publication Date Title
ZA202002139B (en) Combination pharmaceutical agents as rsv inhibitors
EA201790389A1 (en) PYRROPYRIMIDINE COMPOUNDS USED AS AN AGLIST TLR7
BR112018015289A2 (en) benzopyrazole compounds and analogs thereof
EA201500923A1 (en) SUBSTITUTED (BENZYL CYANOMETHYL) AMIDA 2-AZABICYCLO [2.2.1] HEPTAN-3-CARBON ACIDS AS KATPSIN C INHIBITORS
ATE538774T1 (en) PHARMACEUTICAL FORMULATIONS AND METHODS FOR TREATING RESPIRATORY INFECTIONS
MX2008010222A (en) Nebulised antibiotics for inhalation therapy.
EA200971096A1 (en) THERAPEUTIC COMPOSITIONS AND THEIR APPLICATION
EA202190567A1 (en) SPECIAL COMBINED COMPOSITIONS OF INHALED NINTEDANIB AND NINTEDANIB SALTS
EA201791780A1 (en) TIOTROPY INHALATION SOLUTION FOR NONBULIZER SPRAYING
NZ607580A (en) N-heteroaryl compounds
EA200970534A1 (en) ANTIBACTERIAL DERIVATIVES OF QUINOLINE
WO2015160907A3 (en) Potent and selective inhibitors of hepatitis c virus
EA202190398A1 (en) CONDENSED RING DERIVATIVE USED AS FGFR4 INHIBITOR
EA201491982A1 (en) ANTIBACTERIAL QUINOLINE DERIVATIVES
EA201401238A1 (en) Fluoro-substituted (3R, 4R, 5S) -5-GUANIDINO-4-ACYLAMINO-3- (PENTAN-3-ILOXI) CYCLOHEXEN-1-CARBONIC ACIDS, THEIR ETHERS AND METHOD OF APPLICATION
EA202090066A1 (en) THERAPEUTIC FOR THE TREATMENT OF ASPIRATED PNEUMONIA, PULMONARY FORCING OR LUNG ABCESS
BR112022007299A2 (en) EARLY MANAGEMENT, MITIGATION AND PREVENTION OF SEPSIS AND SEPSIS-LIKE SYNDROMES, INCLUDING NEONATAL ARDS BECAUSE OF INFECTION, INJURY OR IATROGENESIS
EA201791995A1 (en) MEANS FOR THE TREATMENT OF RESPIRATORY INFECTION
PH12019502835A1 (en) Therapeutic agent for aspiration pneumonia, lung suppuration, or lung abscess
MX2018013475A (en) Carboxylic acid for treating/preventing nasal congestion.
EA201890789A1 (en) CONTAINING ZINEOL COMPOSITION FOR THE TREATMENT OF NOSE DISEASES
EA202290157A1 (en) TERTIARY AMINE DERIVATIVES AND THEIR USE FOR THE TREATMENT OF VIRAL INFECTION
EA201491971A1 (en) ANTIBACTERIAL QUINOLINE DERIVATIVES
EA200970537A1 (en) ANTIBACTERIAL DERIVATIVES OF QUINOLINE
JP2020015769A5 (en)